Description

This BioTwin research project, conducted with Al Jalila Children's Specialty Hospital, aims to understand immune dysregulation in Down syndrome. By studying the biological markers present in blood and saliva, the project looks for information that could improve early detection and care. Over 24 months, participants will provide samples at home in order to reveal patterns specific to Down syndrome, contributing to the development of personalized care approaches for a better quality of life.

Eligibility

People diagnosed with Down syndrome

Objective

Understand and improve outcomes for Down syndrome.

Expected outcomes

  • Provide early information on the immune dysregulation associated with Down syndrome.